Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Research governance at the crossroads

A few, high profile disasters in clinical trials in recent years have thrust the area of human subject research into the regulatory spotlight. The US has been quickest to react to public concern by introducing systems to tighten-up oversight mechanisms. The UK is now examining its clinical policies and here the authors question the best way forrward.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

George, A., Gale, R., Winston, R. et al. Research governance at the crossroads. Nat Med 8, 99–101 (2002). https://doi.org/10.1038/nm0202-99

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0202-99

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing